Key result
Younger women (<45 years) had significantly higher agonist-induced platelet aggregation than men and post-menopausal women, while spontaneous aggregation was lowest in the mid-luteal phase.
Why the study?
Does age, gender, menstrual cycle phase, or oral contraceptive use affect platelet function in healthy individuals?
Observational (n=114)
No
Does age, gender, menstrual cycle phase, or oral contraceptive use affect platelet function in healthy individuals?
Fertile age in women is associated with higher agonist-induced platelet aggregation capacity, which is not altered by the menstrual cycle or oral contraceptives, though spontaneous aggregation is affected by hormonal fluctuations.
May warrant age- and sex-specific platelet test references; leaves open links to thrombotic risk in premenopausal women.
Platelets are needed to prevent or arrest bleeding and aggregate at the site of injury upon vascular damage. Platelets express receptors for estrogens which might affect the function of the platelets and their hemostatic ability. The aim was to identify possible differences in platelet function related to age, gender, and phases of the menstrual cycle by use of impedance aggregometry with Multiplate. In the first part of the study, platelet function was assessed in 60 healthy individuals (30 men and 30 women) in each of three age groups (20-25, 40-45, and 60-65 years). In the second part of the study, the platelet function was analyzed on four occasions during the menstrual cycle in women without oral contraceptives (OCs) (n = 17) and compared to 19 women on OCs and 18 men of similar age (20-40 years). For the women on OCs, aggregation was analyzed once during the tablet-free week and once late during the period with OCs. The men were sampled once. Women of younger age (<45 years) had significantly higher agonist-induced aggregation response than both men and post-menopausal women (60-65 years). The agonist-induced aggregation response did not differ between phases of the menstrual cycle or OC use. The results suggest that estradiol and/or progesterone affect spontaneous aggregation since it was found to be lowest in the mid-luteal phase. Spontaneous aggregation was significantly lower in women on OCs than in both men and women without OCs. Our findings indicate that fertile age is associated with higher aggregation response capacity of the platelets, possibly to prevent excessive bleeding during menstruation, but this response capacity is not altered during the menstrual cycle or by use of OCs.
No takes yet. Share an insight, caveat, or question.
Berlin et al. (2018) conducted an observational in Healthy individuals (n=114). Menstrual cycle phases and oral contraceptive use vs. Men and post-menopausal women was evaluated on Platelet aggregation response assessed by impedance aggregometry. Younger women (<45 years) had significantly higher agonist-induced platelet aggregation than men and post-menopausal women, while spontaneous aggregation was lowest in the mid-luteal phase.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: